Display Settings:

Format

Send to:

Choose Destination
    Crit Care. 2009;13(6):235. Epub 2009 Dec 21.

    Clinical review: primary influenza viral pneumonia.

    Source

    Critical Care Department, Joan XXIII University Hospital, CIBERES Enfermedades Respiratorias, IISPV, Tarragona, Spain. jrello.hj23.ics@gencat.cat

    Abstract

    Primary influenza pneumonia has a high mortality rate during pandemics, not only in immunocompromised individuals and patients with underlying comorbid conditions, but also in young healthy adults. Clinicians should maintain a high index of suspicion for this diagnosis in patients presenting with influenza-like symptoms that progress quickly (2 to 5 days) to respiratory distress and extensive pulmonary involvement. The sensitivity of rapid diagnostic techniques in identifying infections with the pandemic 2009 H1N1v influenza strain is currently suboptimal. The most reliable real-time reverse transcriptase-polymerase chain reaction molecular testing is available in limited clinical settings. Despite 6 months of pandemic circulation, most novel H1N1v pandemic strains remain susceptible to oseltamivir. Ensuring an appropriate oxygenation and ventilation strategy, as well as prompt initiation of antiviral therapy, is essential in management.

    PMID:
    20085663
    [PubMed - indexed for MEDLINE]
    PMCID: PMC2811908
    Free PMC Article

    Images from this publication.See all images (2) Free text

    Figure 1
    Figure 2

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk